Skip to main navigation
Skip to search
Skip to main content
University of Eastern Piedmont Home
Italiano
English
Search content at University of Eastern Piedmont
Home
Profiles
Research units
Equipment
Projects
Research output
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression
Lorena Quirico
,
Francesca Orso
, Carla L. Esposito
, Sofia Bertone
, Roberto Coppo
, Laura Conti
, Silvia Catuogno
, Federica Cavallo
, Vittorio de Franciscis
, Daniela Taverna
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Melanoma Progression
100%
Breast Cancer Progression
100%
MiR-148a
100%
Chimeric Aptamer
100%
Cancer Cells
25%
Tumor Progression
25%
Metastasis Formation
25%
Aptamer
25%
Breast Cancer
12%
Apoptosis
12%
Overexpression
12%
Tumor Cells
12%
Gene Expression
12%
Melanoma
12%
High Selectivity
12%
Necrosis
12%
Tyrosine Kinase Receptor
12%
Tyrosine Kinase Oncogene
12%
Therapeutic Potential
12%
MicroRNA
12%
Therapeutic Agents
12%
Non-coding RNA (ncRNA)
12%
High Efficacy
12%
Negative Regulator
12%
Direct Target
12%
Inhibit Tumor
12%
Metastatization
12%
Conjugated Molecules
12%
Antimetastatic
12%
Specific Delivery
12%
Xenotransplant
12%
MiR-214
12%
ALCAM
12%
Pro-metastatic
12%
Mammosphere
12%
Delivery Tool
12%
Integrin α5
12%
Potential Development
12%
Medicine and Dentistry
Breast Cancer
100%
Aptamer
100%
Melanoma
100%
Metastatic Carcinoma
50%
Tumor Progression
50%
Cancer Cell
50%
Conjugate
50%
In Vitro
25%
Programmed Cell Death
25%
Tumor Cell
25%
Carcinogenesis
25%
Necrosis
25%
microRNA
25%
Tyrosine Kinase Receptor
25%
Gene Expression
25%
Xenograft
25%
Small Untranslated RNA
25%
microRNA 214
25%
Xeno-transplant
25%
Activated Leukocyte Cell Adhesion Molecule
25%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Breast Cancer
100%
Aptamer
100%
Malignant Neoplasm
50%
Tumor Growth
50%
Neoplasm
25%
Carcinogenesis
25%
Necrosis
25%
Tyrosine Kinase Receptor
25%
microRNA
25%
Small Untranslated RNA
25%
Activated Leukocyte Cell Adhesion Molecule
25%
microRNA 214
25%
Immunology and Microbiology
Cancer Cell
100%
Conjugate
100%
Tumor Cell
50%
Gene Expression
50%
ALCAM
50%
ITGA5
50%
Programmed Cell Death
50%
Tyrosine
50%
Biochemistry, Genetics and Molecular Biology
Aptamer
100%
Tumor Progression
50%
Cancer Cell
50%
Conjugate
50%
Gene Expression
25%
Carcinogenesis
25%
Tyrosine Kinase Receptor
25%
MicroRNA
25%
Non-Coding RNA
25%
ITGA5
25%
Activated Leukocyte Cell Adhesion Molecule
25%
Programmed Cell Death
25%